Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the recommended phase II dose of clofarabine when
administered in combination with standard dose Ara-C to older (>=60 years of age) patients
with newly diagnosed acute myeloid leukemia (AML).